Spots Global Cancer Trial Database for cervarix
Every month we try and update this database with for cervarix cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents | NCT00534638 | Infections, Pap... | Cervarix Engerix-B | 12 Years - 15 Years | GlaxoSmithKline | |
| Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females | NCT01031069 | Infections, Pap... Papillomavirus ... | GSK Biologicals... Merck's Human P... | 15 Years - 25 Years | GlaxoSmithKline | |
| Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination | NCT01082861 | Human Papilloma... | Cervarix Engerix-B | 11 Years - 12 Years | National Institute for Public Health and the Environment (RIVM) | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| Reactogenicity Study of Cervarix and Gardasil in UK Adolescent Girls | NCT00956553 | HPV Infections | Cervarix Gardasil | 13 Years - 15 Years | Public Health England | |
| Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females | NCT00586339 | Infections, Pap... | Cervarix Placebo Control | 18 Years - 25 Years | GlaxoSmithKline | |
| Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka | NCT01551537 | Human Papilloma... | Cervarix data c... Data Collection | 10 Years - | GlaxoSmithKline | |
| Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs | NCT00541970 | Infections, Pap... | Cervarix Placebo | 9 Years - 25 Years | GlaxoSmithKline | |
| Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older | NCT00294047 | Infections, Pap... Papillomavirus ... | Cervarix Placebo control | 26 Years - | GlaxoSmithKline | |
| Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents | NCT00534638 | Infections, Pap... | Cervarix Engerix-B | 12 Years - 15 Years | GlaxoSmithKline | |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study | NCT03355820 | Cervical Intrae... | Blood sampling ... | 17 Years - | GlaxoSmithKline | |
| FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program | NCT03105856 | Cervical Intrae... HPV-Related Cer... | CERVARIX GARDASIL | 25 Years - 45 Years | Instituto Nacional de Salud Publica, Mexico | |
| A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards. | NCT00730847 | Human Papilloma... | Cervarix | 10 Years - | GlaxoSmithKline | |
| Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs | NCT00541970 | Infections, Pap... | Cervarix Placebo | 9 Years - 25 Years | GlaxoSmithKline |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
